Autoimmune ovarian failure

Infertility and Reproductive Medicine Clinics of North America

Volumn 13, Issue 1, 2002, Pages 65-79

  Bates Jr , G Wright ^a   Hill, Joseph A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLUCOCORTICOID; GONADOTROPIN; IMMUNOMODULATING AGENT;

ADDISON DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; MENOPAUSE; MOUSE; NONHUMAN; OVARY DISEASE; OVARY FUNCTION; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT; T LYMPHOCYTE;

EID: 0036147491     PISSN: 10479422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients
2. Premature ovarian failure
3. The potential of Zona pellucida as a target for immunocontraception
4. Premature ovarian failure
5. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure
6. Immunologic aspects of menopause
7. Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: Association of autoantibodies with endocrine autoimmune disease
8. Reversal of apparent premature ovarian failure in a patient with myasthenia gravis
9. Autoimmune Addison's disease and 21-hydroxylase
10. Localization and characterization of white blood cell populations with the human ovary throughout the menstrual cycles and menopause
11. Islet cell and insulin autoantibodies in organ specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow up study
12. The natural history of adrenal function in autoimmune patients with andrenal autoantibodies
13. Complement fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease
14. The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison's disease)
15. Role of aberrant HLA DR expression and antigen presentation in induction of endocrine autoimmunity
16. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function
17. Inhibition of follicle stimulating hormone receptor binding by circulating immunoglobulins
18. Age at natural menopause and mortality
19. Incidence of premature ovarian failure
20. Premature ovarian failure: Evidence of the autoimmune mechanism
21. Premature ovarian failure
22. Biology of mammalian fertilization
23. Effect of immunization with purified porcine zona pellucida proteins on ovarian function in baboons
24. Autoimmune thyroiditis, adrenalitis, and oophoritis
25. Subsets of CD4+ cells and their roles in the induction and prevention of autoimmunity
26. Autoimmune endocrinopathies in female reproductive dysfunction
27. Frequency of T cell peptid crossreaction determined by experimental autoimmune disease and autoantibody induction
28. Autoimmune oophoritis
29. Gonadotropins in women with amenorrhea
30. Failure of female baboons (Papio anubis) to conceive following immunization with recombinant non-human primate zona pellucida glycoprotein-B expressed in Escherichia coli
31. Le pseudo-panhypopituitarisme par insuffisiences associees ovarienne, thryoidienne, et semenale
32. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study
33. Association of medically treated depression and age at natural menopause
34. Detection of T8 (suppressor/cytotoxic) lymphocytes in human ovarian follicular fluid
35. Induction of class II major histocompatibility complex antigen expression in human granulosa cells by interferon gamma: A potential mechanism contributing to autoimmune ovarian failure
36. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease
37. Expression of human luteinizing hormone receptor: Interaction of LH and chorion gonadotropin from human, but not equine, rat, and ovine species
38. Premature ovarian failure is not premature menopause
39. Etiological implication of auto-antibodies to zona pellucida in human female infertility
40. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure
41. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase
42. Autoimmune etilology in premature ovarian failure
43. Antigen mimicry in autoimmune disease: Sharing of amino acid residues critical for pathogenic T cell activation
44. Rapid induction of autoantibodies by andogenous ovarian antigens and activated T cells: Implication in autoimmunity pathogenesis and B cell tolerance
45. T cell peptide of a self protein elicits autoantibody to the protein antigen: Implications for specificity and pathogenic role in autoimmunity
46. Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies
47. Autoimmune hypogonadism as part of an autoimmune polyglandular syndrome
48. Adaptive transfer of autoimmune diabetes and thryoiditis in athymic rats
49. The cytotoxic effect of serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cell in culture
50. Premature ovarian failure
51. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: A controlled trial
52. Two types of autoimmune Addison's disease associatd with different polyglandular autoimmune (PGA) syndromes
53. Analysis of contraceptive potential of antibodies against native and deglycosylated porcine ZP3 in vivo and in vitro
54. Immunologic disturbances in patients with premature ovarian failure
55. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in autoimmune disease and by pancreatic beta cells in type I diabetes
56. Lymphocytic dysfunction in autoimmune oophoritis. Resumption of menses with corticosteroids
57. Premature ovarian failure
58. Clinical features of young women with hypergonadotropic amenorrhea
59. Autoimmune disease of the ovary induced by ZP3 peptide from the mouse zona pellucida
60. Ovaries remain functional in squirrel monkeys immunized with porcine zona pellucida 55,000 macro-molecules
61. r = 55,000) macromolecules
62. Organ specific autoimmune disease induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self tolerance: Defect of a T cell subset as a possible cause of autoimmune disease
63. Study in cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirements of Lyt-1 cells in normal female mice for the prevention of oophoritis
64. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women
65. Autoimmune oophoritis: A histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate
66. Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus
67. Tolerance mechanisms in ovarian and gastric autoimmune disease
68. Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy
69. Is early natural menopause a biologic marker of health and aging?
70. Immunofluorescence studies on autoantibodies to steroid-producing cells and to germline cells in endocrine disease and infertility
71. The day 3 thymectomy model of organ-specific autoimmunity
72. The limitations of laparoscopic ovarian biopsy
73. Autoimmune oophoritis in thymectomized mice: Detection of circulating antibodies against oocytes
74. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
75. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin-2 production
76. Gonadotropins enhance HLA-DR antigen expression in human granulosa cells
77. Expression of recombinant human follicle-stimulating hormone receptor: Species-species ligand binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts
78. Autoimmune ovarian disease induced by immunization with ZP3 peptide
79. Autoimmune ovarian disease: Mechanism of induction and prevention
80. Extra-adrenal endocrine deficiencies in Addison's Disease
81. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease
82. Immunization of monkeys with recombinant cDNA expressed zona pellucida proteins
83. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease
84. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease
85. Identification of premature ovarian failure patients with underlying autoimmunity